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Abstract
Background: In Peru, cardiovascular disease was the second most common cause of death in
those aged 65 years or more in 2000. Hypertension is a major modifiable risk factor for
cardiovascular disease, and if treated can significantly reduce cardiovascular disease risk. The
objectives of this study were to investigate the prevalence of hypertension and levels of awareness,
treatment and control in a deprived urban area of Peru.
Methods: A cross-sectional study was completed. Blood pressure measurements were recorded
in triplicate. Hypertension was defined as systolic blood pressure ≥ 140 mmHg or diastolic blood
pressure ≥ 90 mmHg, or self report of receiving antihypertensive medication at the time of
interview.
Results: The study sample was 584 adults (29.1% male, mean age 35.3 years). Age standardized
prevalence of hypertension was 19.5% (95% CI 9.9%, 29.1%) in men, 11.4% (95% CI 3.7%, 19.1%)
in women, and 13.2% (95% CI 5.0%, 21.5%) overall. Among those with hypertension 38.3% (95%
CI 22.7%, 53.9%, n = 18/47) were aware of their condition with greater awareness among women
than men. Of those aware, 61.1% (n = 11/18) were treated, equating to 23.4% (95% CI 10.1%,
36.7%, n = 11/47) of all adults with hypertension. Of those treated 63.6% (n = 7/11) had controlled
hypertension, equating to 14.9% (95% CI 3.0%, 26.8%, n = 7/47) of all adults with hypertension.
Conclusion: Levels of awareness and control in this population were low. Lack of control is likely
to be due to both a failure to diagnose hypertension, especially among men, and initiate or comply
with treatment, especially among women. These results suggest a considerable burden of
undiagnosed hypertension, and poor levels of control in those treated, in a deprived urban area of
Lima, Peru.
Background
Non-communicable diseases (NCD) are emerging as a
major concern for health in developing countries [1]. In
2000, two thirds of all deaths in Latin America and the
Caribbean were due to NCDs, with cardiovascular disease
(CVD) alone accounting for 31% of deaths [2]. In Peru,
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CVD was the second most common cause of death in
those aged 65 years or more (mortality rate 4 per 1000
population) in 2000. Ischaemic heart disease, heart fail-
ure and hypertension are also among the ten most com-
mon causes of death reported in this age group [3]. The
increasing importance of cardiovascular disease in Latin
American has been commented on [2,4,5] and the need
for preventative action to be taken to limit, or prevent, a
predicted epidemic of cardiovascular disease has been
highlighted [6].
Hypertension is a major modifiable risk factor for CVD,
and if treated can significantly reduce the risk of CVD.
Despite this, many countries, including Europe, America
and South Africa, have reported a high proportion of
adults with hypertension remain unaware of their condi-
tion and fail to be treated [7-11]. Studies investigating
hypertension in Peru are scant, with estimates of the prev-
alence of hypertension range from 16% to 31% in men,
and 15% to 23% in women depending on the population
studied [12-15]. In some regions of Peru it has been found
that approximately 50% of adults with hypertension are
unaware of their condition and in many their condition is
poorly controlled [12,14]. In this study, we report the
prevalence of hypertension in adults in a deprived urban
area of Lima, Peru, and provide information on the diag-
nosis and treatment of hypertension among this popula-
tion.
Methods
In 2001, newborn children were enrolled in a cohort
study established for diarrhoeal disease surveillance in
San Juan de Miraflores, a deprived urban area of Lima,
Peru. This cohort followed similar methodologies to pre-
vious diarrhoeal studies carried out by our research group
in the same area before [16,17]. Enrolled children acted as
the index children from which adult family members were
invited to participate in a cross-sectional study on hyper-
tension, the results of which are presented in this paper. In
2006, 497 index children were revisited and adult (aged
>17 years) family members living in the same house as
each child were invited to participate in the hypertension
study. Informed consent was obtained. No information
was recorded on adults who declined to participate. Par-
ticipating adults were asked if they had ever had a medical
diagnosis of hypertension, and if they were prescribed
anti-hypertensive medications. Age, height and weight
were recorded at interview and the body mass index (BMI)
calculated (kilogram per metre2). BMI was classified as
not overweight (BMI<25), overweight (25 ≤ BMI <30) or
obese (BMI ≥ 30). Household bedroom ratio (number of
household residents per bedroom) and number of years
of education were obtained from the diarrhoeal cohort
dataset. Blood pressure (BP) was measured using appro-
priate cuffs for arm circumference and measurements
recorded in triplicate. The BP mean of the last two systolic
and diastolic measurements were used in the analysis.
Hypertension was defined as systolic blood pressure
(SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥
90 mmHg [18,19], or self report of receiving antihyper-
tensive medication at the time of interview. Prevalence is
the proportion of adults with hypertension and presented
as a percentage. Direct standardisation was used to calcu-
late age-standardized prevalence of hypertension by
applying age group-specific prevalence (five yearly age
groups: 20–24, 25–29 up to 70+ years) to the World
Health Organization standard population [20]. Differ-
ences between those with hypertension and without were
compared using logistic regression and odds ratios (OR)
and their 95% confidence intervals (CI) are presented.
Multiple adults were recruited within a single family unit,
and so all analyses were adjusted for the clustering at fam-
ily unit level. Awareness was defined as the proportion of
hypertensive adults reporting a prior medical diagnosis of
hypertension or high BP. Controlled hypertension was
defined as SBP < 140 mm Hg and DBP < 90 mmHg. Ethi-
cal approval was granted by the Universidad Peruana
Cayetano Heredia ethics committee.
Results
A total of 584 adults agreed to participate, representing
67.8% of the families visited (337/497). Only one adult
was recruited from 166 family units, and multiple adults
were recruited from the remaining 331 families (average
number of adults per family unit 1.3 (range 2 to 10)). The
majority of the participants (61.0%) were parents of the
children recruited in the cohort.
Of the 584 (29.1% male) adults interviewed the mean age
was 35.3 years (95% CI 34.4, 36.3). The mean age was
36.7 (95% CI 34.8, 38.7) years in men and 34.8 (95% CI
33.7, 35.8) years in women. Characteristics of the study
population are provided in Table 1. Information on BMI
was available for 579 adults, 42.1% of whom were over-
weight, and 18.2% obese. A greater proportion of women
were obese compared to men (F statistic = 6.4, p = 0.002).
The majority of adults had some level of education, but a
greater proportion of men reported levels of secondary
education (67.1%) compared to women (49.0%).
The mean SBP was 119.3 mmHg (SE 1.0) in men and
109.5 mmHg (SE 0.7) in women. The mean DBP was 74.9
mmHg (SE 0.8) in men and 68.2 mmHg (SE 0.6) in
women (Table 1). A positive correlation between BP and
age was found, with a single year increase in age equating
to a 0.5 mmHg (95% CI 0.4, 0.6, p < 0.001) increase in
SBP and a 0.2 mmHg (95% CI 0.1, 0.3, p < 0.001) increase
in DBP. Forty-seven adults had evidence of hypertension,
equating to a crude prevalence of 8.0% (95% CI 5.8%,
10.3%) in the study population. Hypertension was moreBMC Research Notes 2008, 1:2 http://www.biomedcentral.com/1756-0500/1/2
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prevalent in men compared with women, and increased
with increasing age group (Table 1). Age standardized
prevalence of hypertension was 13.2% (95% CI 5.0%,
21.5%), and greater in men (19.5% (95% CI 9.9%,
29.1%)) than women (11.4% (95% CI 3.7%, 19.1%)).
Among those with untreated hypertension the predomi-
nant type of hypertension was isolated diastolic hyperten-
sion (42.5%, 17/40) compared to isolated systolic
hypertension (27.5%, 11/40) and systodiastolic hyperten-
sion (30.0%, 12/40).
The crude odds of hypertension in men were twice that
found in women (Table 2), but after adjusting for explan-
atory factors in the multivariate analysis no evidence of a
sex difference in the prevalence of hypertension remained.
In the crude logistic regression there was some evidence to
suggest that the odds of hypertension were greater in
those overweight or obese, and in those with no educa-
tion, however these associations were not found in the
multivariate analysis (Table 2). There was strong evidence
of an increasing odds of hypertension with increasing age,
and this remained after adjustment for other explanatory
factors (Table 2).
Only one third (38.3% (95% CI 22.7%, 53.9%)) of all
hypertensive adults were aware of their condition (Figure
1). There was evidence to suggest a greater proportion of
women (55.6% (95% CI 34.9%, 76.2%), n = 15/27) were
aware of their hypertension, compared to men (15.0%
(95% CI -2.1%, 32.1%), n = 3/20) (F statistic = 8.5, p
value = 0.006). A trend of increasing awareness with
decreasing household bedroom ratio, an indicator of
socio-economic status, was found (F statistic = 2.8, p =
0.042). There was no evidence to suggest a difference in
awareness with age (F statistic = 0.9, p = 0.419), and no
evidence of greater awareness in the obese compared to
the non-obese (F statistic = 3.1, p = 0.084). Among adults
aware of their hypertension 61.1% (95% CI 36.3%,
85.9%, n = 11/18) reported receiving anti-hypertensive
medication, equating to 23.4% (95% CI 10.1%, 36.7%, n
= 11/47) of all adults with hypertension (Figure 1).
Although the numbers are small there was some evidence
Table 1: Baseline descriptive information, mean and standard error diastolic and systolic blood pressure measurements and 
hypertension prevalence among adults in San Juan de Miraflores region of Lima, Peru, 2006.
Men
(n = 170)
Women
(n = 414)
p value Total
(n = 584)
Age group (n, %) 0.1611
<30 years 49 (28.8) 146 (35.3) 195 (33.4)
30–49 years 103 (60.6) 237 (57.3) 340 (58.2)
50+ years 18 (10.6) 31 (7.5) 49 (8.4)
BMI (n, %) 0.0021
Not overweight 78 (45.9) 149 (36.0) 227 (38.9)
Overweight 73 (42.9) 173 (41.8) 246 (42.1)
Obese 16 (9.4) 90 (21.7) 106 (18.2)
Missing 3 (1.8) 2 (0.5) 5 (0.9)
Household bedroom ratio (quartiles) 0.0211
1 (lowest) 38 (22.4) 81 (19.6) 119 (20.4)
2 29 (17.1) 77 (18.6) 106 (18.2)
3 29 (17.1) 91 (22.0) 120 (20.6)
4 (highest) 65 (38.2) 113 (27.3) 178 (30.5)
Missing 9 (5.3) 52 (12.6) 61 (10.5)
Number of years of education 0.0051
0 1 (0.6) 6 (1.5) 7 (1.2)
1 to 6 27 (15.9) 101 (24.4) 128 (21.9)
7 to 11 114 (67.1) 203 (49.0) 317 (54.3)
12 to 21 13 (7.7) 44 (10.6) 57 (9.8)
Missing 15 (8.8) 60 (14.5) 75 (12.8)
Systolic blood pressure (mmHg, SE) 119.3 (1.0) 109.5 (0.7) <0.0012
Diastolic blood pressure (mmHg, SE) 74.9 (0.8) 68.3 (0.6) <0.0012
Prevalence of hypertension (%, 95% CI)
<30 years 0 2.7 (0.1, 5.4) 0.2331 2.1 (0, 4.1)
30–49 years 14.6 (7.6, 21.5) 5.9 (2.9, 8.9) 0.0081 8.5 (5.5, 11.6)
50+ years 27.8 (6.0, 49.5) 29.0 (12.1, 46.0) 0.9271 28.6 (16.2, 41.0)
Crude (all ages) 11.8 (6.9, 16.7) 6.5 (4.1, 8.9) 0.0361 8.0 (5.8, 10.3)
Age standardized3 (20 to 70+ years) 19.5 (9.9, 29.1) 11.4 (3.7, 19.1) 0.6742 13.2 (5.0, 21.5)
1cluster design based p value from F statistic; 2z test; 3Standardized to the World Health Organization world population standard; SE standard 
error; CI confidence interval.BMC Research Notes 2008, 1:2 http://www.biomedcentral.com/1756-0500/1/2
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of a sex difference in the treatment of hypertension, with
only 53.3% (95% CI 26.4%, 80.2%, n = 8/15) of the
women aware of their hypertension receiving treatment,
compared to all of the men (100%, n = 3/3). Among
treated, 63.6% (95% CI 27.3%, 100.0%, n = 7/11) had
controlled hypertension, equating to only 14.9% (95% CI
3.0%, 26.8%, n = 7/47) of all adults with hypertension.
Discussion
In our study, we report the age standardised prevalence of
hypertension among young adults in a deprived urban
area of Lima was 13.2% (95% CI 5.0%, 21.5%). Overall,
38% (95% CI 22.7%, 53.9%) of all adults with hyperten-
sion were aware of their diagnosis, 23% (95% CI 10.1%,
36.7%) were receiving treatment, and control was
achieved in only 15% (95% CI 3.0%, 26.8%) of hyperten-
sive adults.
Comparison with other studies
The crude prevalence of hypertension found in this study
(8.0% (95% CI 5.8%, 10.3%)) was lower than that
reported by other studies in Peruvian populations and
this is likely to reflect the young age of our study popula-
tion [12-15]. A cross-sectional study of the adult popula-
tion in Peru by the Peruvian Society of Cardiology
reported a national prevalence of 23.7% (men 27.1%,
women 20.4%), but prevalence was lower (15.3%) in the
south of Lima, the geographical region most comparable
to our study [12]. More robust estimates of prevalence are
available from the PREVENCION study carried out in a
large city in the mountainous regions of Peru. The preva-
lence of hypertension found among a representative pop-
ulation of adults with an older mean age that our study
population (49.1 compared to 35.3 years) was 15.7%
(95% CI 14.0 to 17.4%) [14].
Awareness
We found that 38% of adults with hypertension were
aware of their condition, and awareness was much greater
in women compared to men. Similar levels of awareness,
and supporting evidence of a sex difference in awareness,
have been reported by other studies in Peru [12,14].
Awareness in Peru is low compared to international esti-
mates, for example a study in Sao Paulo, Brazil, reported
three quarters of those with hypertension were aware of
their condition [21]. A review of hypertension in national
representative population surveys completed in the 1990s
reported the awareness among the adult (35 to 64 years)
population was 69% in America, 63% in Canada, and
ranged from 36 to 52% in five European countries
[11,22].
Table 2: Crude and adjusted odds ratio for risk factors for hypertension among adults in San Juan de Miraflores region of Lima, Peru, 
2006.
Crude Adjusted1 (n = 505)
Odds ratio
(95% CI)
p value Odds ratio
(95% CI)
p value
Sex
Female 1 1
Male 1.9 (1.0, 3.5) 0.038 1.7 (0.8, 3.3) 0.135
Age group
>30 years 1 1
30–49 years 4.5 (1.6, 12.7) 0.005 4.5 (1.3, 15.4) 0.018
50+ years 19.1 (6.1, 60.2) <0.001 18.9 (4.9, 73.1) <0.001
BMI
Not overweight 1 1
Overweight 2.5 (1.2, 5.2) 0.018 1.9 (0.8, 4.7) 0.138
Obese 2.3 (0.9, 5.7) 0.085 2.2 (0.8, 6.1) 0.133
Household bedroom ratio (quartiles)
1 (lowest) 1 1
2 0.7 (0.3, 1.7) 0.439 1.1 (0.4, 2.6) 0.880
3 0.5 (0.2, 1.2) 0.102 0.7 (0.2, 1.7) 0.395
4 (highest) 0.4 (0.2, 1.0) 0.049 0.6 (0.2, 1.4) 0.222
Number of years of education
0 11.0 (1.2, 98.4) 0.032 1.1 (0.1, 21.7) 0.936
1 to 6 2.6 (0.6, 12.4) 0.234 1.8 (0.3, 9.4) 0.499
7 to 11 2.5 (0.5, 11.0) 0.238 2.3 (0.5, 11.3) 0.311
12 to 21 1 1
1 adjusted for all other variables listed in the table; CI confidence interval. Adjusted for clustering.BMC Research Notes 2008, 1:2 http://www.biomedcentral.com/1756-0500/1/2
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Controlled hypertension
In our study population only 23% of those with hyperten-
sion were receiving pharmaceutical treatment and hyper-
tension control was achieved in two thirds of those
treated. These estimates are comparable to that reported
by the PREVENCION study (39.5% treated, 35.7% con-
trolled among those treated) [14] and the national survey
(28.1% treated, 23.6% controlled among those treated)
[12]. Treatment levels in Peru are much lower than in
America (53%), Canada (36%), Europe (25 to 60%) and
Brazil (62%) [11,21-23]. The lower treatment rates found
in Peru may be due to social and cultural differences, for
example adults tend to attend a doctor or take medication
only if they feel ill. This may result in low diagnosis rates
and reduce the opportunity to provide treatment and
advice on the importance of compliance. In addition,
there are economic factors to consider as adults must pay
for prescribed medications in Peru.
Among those aware of their hypertension we found evi-
dence to suggest women were less likely to be treated than
men. This may be due to the small numbers investigated,
as no sex difference in treatment was found in the PRE-
VENCION study [14]. However, it may also reflect gender
differences in access to treatment despite being aware of
their condition. Further investigation is needed to deter-
mine if there is a true sex difference in treatment among
this poor population, and if so, to explore the possible
underlying reasons. Encouragingly we found hyperten-
sion was controlled in two thirds of the adults treated,
which is comparable to other developed countries. How-
ever, this equates to achieving control in only 15% of all
adults with hypertension, which is comparable to that
reported in other areas of Peru [12,14]. Lack of control
among our study population is likely to be due to both a
failure to diagnose hypertension, especially among men,
and initiate or comply with treatment, especially among
women. Over time, as the patient ages, uncontrolled
hypertension can result in more severe cardiovascular
problems. To find this level of uncontrolled hypertension
among a relatively young population is of cause for con-
cern, as the detrimental effects on health will increase as
the population ages.
Strengths and weaknesses
This is a descriptive observational study and, as such, has
a number of limitations. A possible sampling bias, due to
the selection of adults from families who had already
The proportion awareness, treatment and control among hypertensive adults in San Juan de Miraflores region of Lima, Peru,  2006 Figure 1
The proportion awareness, treatment and control among hypertensive adults in San Juan de Miraflores region of Lima, Peru, 
2006.
Hypertensive adults    
n=47
Unaware    n=29 (61.7%)
Aware    n=18 (38.3%)
Treated    n=11 (61.1%) Untreated    n=7 (38.1%)
Controlled    n=7 
(63.6%)
Uncontrolled    n=4 
(36.4%)
Hypertensive adults    
n=47
Unaware    n=29 (61.7%)
Aware    n=18 (38.3%)
Treated    n=11 (61.1%) Untreated    n=7 (38.1%) Treated    n=11 (61.1%) Untreated    n=7 (38.1%)
Controlled    n=7 
(63.6%)
Uncontrolled    n=4 
(36.4%)
Controlled    n=7 
(63.6%)
Uncontrolled    n=4 
(36.4%)BMC Research Notes 2008, 1:2 http://www.biomedcentral.com/1756-0500/1/2
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agreed to their child participating in a diarrhoeal follow
up cohort, could be expected. However, the initial birth
cohort was randomly selected and as being born in a com-
munity is a random process, and family members of each
child were invited to participate based on these index chil-
dren, the adults in this hypertension study may be consid-
ered a quasi-random sample of adults from the area of San
Juan de Miraflores, Lima, Peru. Only a small number of
patients with hypertension were identified, and as a result
of the small sample size the estimates of hypertension
awareness, treatment and control may not be robust and
should be considered with caution. A further limitation of
the small study sample was that men were under-repre-
sented, accounting for less than one third of the adults
interviewed, and as a result the confidence interval for the
estimate of hypertension prevalence among men was
wide. The aim of our study was not to investigate sex dif-
ferences in awareness, treatment and control, and there-
fore such findings should be treated with caution. The
study design meant that some individuals were recruited
from the same family units, or clusters. One consideration
of this type of data is that individuals recruited from the
same family units (or clusters) are likely to be more simi-
lar to each other than to individuals from different fami-
lies. However, the extent of clustering was minimal (one
adult was recruited from 166 family units, and in the
remaining 331 family units (clusters) the average number
of adults recruited from each cluster was 1.3). Further
adjustment for clustering did not affected the point esti-
mates of prevalence and treatment and awareness, and
only had a limited effect on the confidence intervals, e.g.
the crude prevalence of hypertension unadjusted for clus-
tering was 8.0% (95% CI 5.8%, 10.3%) and after adjust-
ment for clustering the confidence interval remained
5.8% to 10.3% due to the very small change to the stand-
ard error. A further limitation of this study is that the esti-
mates of awareness are subject to recall bias, as an
individual's awareness of hypertension was based on self-
report. Finally, although the BP measurements were com-
pleted in triplicate, they were taken only on one day and
it is recommended that a diagnosis of hypertension in
adults be made by multiple BP measurements recorded
on separate occasions [19].
Conclusion
Hypertension is a major modifiable risk factor and if left
uncontrolled it can result in major cardiovascular prob-
lems in later life.Although this study is small and has a
number of limitations it does raise some important ques-
tions about the provision of care and treatment for
patients with hypertension in a deprived urban area of
Peru. The results, along with that from other published
studies indicate a large burden of undiagnosed hyperten-
sion in the population of Peru, and poor levels of control.
This set within the context a country with underlying dif-
ficulties in the provision of health care represents a great
challenge for public health in Peru.
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